Roswell Park receives training accreditation in robotic surgery

Article

Roswell Park Cancer Institute in Buffalo, NY said it has become the first institution in the U.S. to be accredited as a training institute in robot-assisted surgery by the Société Internationale d'Urologie.

Roswell Park Cancer Institute in Buffalo, NY said it has become the first institution in the U.S. to be accredited as a training institute in robot-assisted surgery by the Société Internationale d’Urologie.

The accreditation allows Roswell Park to participate in the SIU scholarship program for young urologists. These awards provide 3-month robot-assisted mini fellowships, including laparoscopic and robot-assisted skills development and case observership, to promising physicians early in their careers.

"As new technologies and tools change the look, feel, and structure of urologic practice, high-impact training with experienced surgeons becomes ever more vital," said Khurshid Guru, MD, director of the Center for Robotic Surgery at Roswell Park.

"What’s missing at many institutions is a good training environment. Here at RPCI we have, with the help of the John R. Oishei Foundation, developed an advanced robot-assisted surgery program that trains novice surgeons through more than 10 hours of assimilation-based console time, thereby introducing them to safe basic robot-assisted surgery."

"We’re eager to pass along insight and practical guidance on the use of robot-assisted cancer surgery to young surgeons through the SIU fellowships," added James Mohler, MD, chair of the department of urology and associate director of RPCI.

Recent Videos
Elisabeth M. Sebesta, MD, answers a question during a Zoom video interview
Kyrollis Attalla, MD, an expert on prostate cancer
Kyrollis Attalla, MD, an expert on prostate cancer
Marc Bjurlin, DO, MSc, FACOS, answers a question during a Zoom video interview
Jacqueline Zillioux, MD, answers a question during a Zoom video interview
DNA molecules | Image Credit: © vitstudio - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.